エピソード

  • Episode 42: “Brain Fog + Hair Loss? Don’t Blame Menopause Yet: Your Iron May Not Be as ‘Normal’ as You Think”

    Episode 42: “Brain Fog + Hair Loss? Don’t Blame Menopause Yet: Your Iron May Not Be as ‘Normal’ as You Think”
    2026/09/30

    Brain fog? Hair shedding? Restless legs? Before you automatically blame menopause, it may be time to take another look at your iron.


    New 2026 guidelines are changing how iron deficiency is diagnosed, and yes, you can have iron deficiency even when you're not anemic.


    In Episode 42 of The Modern Midlife Collective, Dr. Jillian Woodruff and Dr. Ade Akindipe unpack the newly released American Society of Hematology guidelines on diagnosing iron deficiency.


    We're going beyond the symptom everyone already knows, fatigue, and talking about the signs midlife women may not associate with iron:

    • Brain fog and difficulty concentrating
    • Hair and nail changes
    • Restless legs
    • Poor exercise tolerance
    • Mood changes
    • Pica and ice chewing
    • Heavy menstrual bleeding during perimenopause


    You'll also learn why a “normal” CBC doesn't automatically rule out iron deficiency, what ferritin tells us, why laboratory reference ranges aren't always the same as clinical decision thresholds, and why finding low iron should prompt another important question:


    Why is the iron low in the first place?


    In this episode:

    • Iron deficiency vs. iron-deficiency anemia
    • The new 2026 ferritin diagnostic thresholds
    • Why brain fog isn't automatically menopause
    • The complicated connection between iron and hair loss
    • Heavy periods and iron depletion during perimenopause
    • Why postmenopausal iron-deficiency anemia needs further evaluation
    • Ferritin, CBC and transferrin saturation
    • Why you shouldn't automatically start iron supplements
    • Three questions to take to your next medical appointment


    Your three questions:

    1. What was my actual ferritin?
    2. Could I have iron deficiency even though I'm not anemic?
    3. If my iron is low, why is it low?


    Resources

    American Society of Hematology: 2026 Guidelines on Diagnosis of Iron Deficiency
    CMAJ: Diagnosis and Management of Iron Deficiency in Females
    JAMA: Iron Deficiency in Adults: A Review
    American Gastroenterological Association: GI Evaluation of Iron Deficiency Anemia
    American Academy of Sleep Medicine: Treatment of Restless Legs Syndrome Guideline


    The Modern Midlife Collective
    Because thriving at 40 and beyond isn't just possible. It's your birthright.
    続きを読む 一部表示
    45 分
  • Episode 41: The Estrogen Lie, Revisited

    Episode 41: The Estrogen Lie, Revisited
    2026/09/16
    Back in Episode 20, Dr. Jill and Dr. Ade covered the FDA's decision to walk back twenty years of black box warnings on hormone therapy. Since then, hormone therapy has become a genuine moment on social media, and not always an accurate one. In this quick-turnaround update, they separate what the newest research actually shows from what the internet is claiming, including a new Stanford study linking estrogen-only therapy to lower Alzheimer's markers, why that finding does not extend to combined therapy, and what the twenty-year-old dementia data really pins the risk on.Segment GuideCold open: What changed since Episode 20, and why this update existsThe quick WHI recap, done right: relative risk versus absolute risk, and the age-stratified "timing hypothesis"What the FDA actually changed, and when: the November 2025 label update, and what stayed in placeWhat's actually prescribed now versus what WHI tested: bioidentical estradiol and micronized progesterone versus the oral synthetic combination used in the original trial, including how the two progestogens differ at the receptor levelThe hype swing of 2026: what hormone therapy is well-supported for, and what it is notThe new Stanford Alzheimer's study: what its three parts can and cannot tell us, and why the dementia-risk signal from 2003 traces to one specific drug, not to progesterone as a categoryWhat we'd actually tell a patient: an honest, evidence-based bottom lineKey TakeawaysThe WHI's real numbers are absolute, not relative: about 8 additional breast cancer cases per 10,000 women per year in the combined-therapy arm, not the large-sounding relative-risk percentage that made headlines in 2002.Estrogen-alone therapy showed fewer breast cancer cases in the WHI, a reduction that reached statistical significance in longer-term follow-up along with a reduction in breast cancer mortality.Today's typical prescription, transdermal estradiol with micronized progesterone, is a different drug, different route, and different population than what the original WHI tested.A new Stanford study (Neurology, August 2026) found estrogen-only hormone therapy associated with a roughly 35 percent lower likelihood of Alzheimer's pathology markers on autopsy, plus supporting signals in dementia diagnoses and biomarkers. It is observational, not a randomized trial, and it could not address combined therapy either way due to sample size.The dementia-risk signal from the 2003 WHI Memory Study traces specifically to oral conjugated equine estrogen plus medroxyprogesterone acetate, not to progesterone or progestins as a category. Whether the micronized progesterone used today carries the same risk is a genuinely open question, not a settled no.Formulation matters. Ask your provider exactly what you are being prescribed, oral versus transdermal estrogen, and bioidentical micronized progesterone versus a synthetic progestin.Research and Sources MentionedHHS: Advances Women's Health, Removes Misleading FDA Warnings on Hormone Replacement TherapyNPR, August 7, 2026: Everyone's talking about hormone therapy for menopause. Should I be on it?STAT News, January 8, 2026: Hormone therapy for menopause is being overhyped, againStanford Medicine, August 2026: Study ties estrogen-based menopausal hormone therapy to lower Alzheimer's riskNational Cancer Institute: Menopausal Estrogen Therapy Benefits and Risks Vary by Age (WHI analysis)International Menopause Society: Lessons from KEEPS, the Kronos Early Estrogen Prevention StudyShumaker et al., JAMA, 2003: Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment (WHI Memory Study)Barth et al., Lancet Diabetes & Endocrinology, 2023: Sex Steroids and the Female Brain Across the LifespanVinogradova et al., BMJ, 2021: Use of menopausal hormone therapy and risk of dementia (UK QResearch/CPRD cohort)Savolainen-Peltonen et al., BMJ, 2019: Use of Postmenopausal Hormone Therapy and Risk of Alzheimer's Disease in FinlandGleason et al., PLOS Medicine, 2015: Effects of Hormone Therapy on Cognition and Mood (KEEPS-Cognitive and Affective Study)A Note on This EpisodeThis episode is for educational purposes and reflects Dr. Jill and Dr. Ade's read of the current evidence. It is not personalized medical advice. Hormone therapy decisions depend on individual history, and listeners should talk with their own healthcare provider before starting, stopping, or changing any hormone therapy.Connect With UsHave a question about your own hormone therapy, or a topic you want us to cover? Email connect@modernmidlifecollective.com or visit www.modernmidlifecollective.com for links to everything mentioned in this episode.If this episode was useful, follow or subscribe wherever you listen, and consider leaving a rating and review. It genuinely helps other midlife women find the show.
    続きを読む 一部表示
    30 分
  • Episode 40: “Why Can't I Drink Like I Used To? The Truth About Alcohol in Perimenopause”

    Episode 40: “Why Can't I Drink Like I Used To? The Truth About Alcohol in Perimenopause”
    2026/09/02
    One completely ordinary glass of wine.Then suddenly you’re awake at 3 a.m., your heart is racing, you’re hot, your sleep is wrecked, your stomach feels off—and the next morning feels suspiciously like a hangover that should have required a much bigger night out.Sound familiar?In this episode of The Modern Midlife Collective, Dr. Jillian and Dr. Ade explore why many women notice that alcohol affects them differently during perimenopause and menopause.And while hormones are part of the conversation, the answer is much more nuanced than “your estrogen dropped.”Alcohol is landing in a body that may now have different body composition, total body water, sleep architecture, medications, metabolic demands and nervous-system vulnerability—all while estrogen is becoming increasingly unpredictable during the menopause transition.This episode is about recalibration, not perfection.No shame. No judgment. No gold stars for abstinence.Just better information.IN THIS EPISODEDr. Jillian and Dr. Ade discuss:Why alcohol may suddenly feel stronger in midlifeWhy perimenopause is better described as hormonal turbulence than a simple estrogen declineHow alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH2) metabolize alcoholWhy genetic differences can dramatically affect alcohol toleranceHow lower total body water can contribute to higher blood-alcohol concentrationsAge-related changes that may affect the “bounce-back”Why alcohol may make you sleepy while still disrupting restorative sleepREM sleep and those notorious 3 a.m. awakenings“Hangxiety” and the nervous-system rebound after alcoholAlcohol as a potential hot-flash or night-sweat triggerWhy different drinks may feel different—even though ethanol is still ethanolHistamine, sulfites and why red wine may suddenly make some women miserableWhy “red wine is good for your heart” deserves more nuanceAlcohol and breast-cancer riskAlcohol’s effects on appetite, weight-management goals and training recoveryWhat to consider if you are taking a GLP-1 medicationBladder urgency, frequency and menopause-related genitourinary symptomsWhy new medications may change your alcohol toleranceWhat we know—and still don’t know—about alcohol and the gut microbiomeHormonal and evidence-based nonhormonal options for bothersome hot flashes and night sweatsThe Two-Week “Does Alcohol Actually Like Me?” ExperimentKEY TAKEAWAYS1. It probably isn’t just one hormone.Estrogen and alcohol do interact, and research has found associations between alcohol exposure and estradiol levels. But current evidence does not support reducing midlife alcohol intolerance to a simple story in which fluctuating estrogen directly “switches off” ADH or ALDH2.Aging, genetics, body composition, sleep, medications, liver physiology and the menopause transition can all overlap.2. The same drink may be landing in a different body.Alcohol distributes through body water. Changes in body composition with aging—including loss of lean tissue when muscle is not actively preserved—can change the physiologic context in which alcohol is consumed.That is one more reason strength training, protein intake and maintenance of lean mass matter in midlife.3. Being able to “hold your liquor” doesn’t make alcohol harmless.Tolerance describes how intoxicated you feel. It does not mean other physiologic effects disappear.4. Alcohol may help you fall asleep—but that doesn’t make it a sleep treatment.A 2025 systematic review and meta-analysis of 27 studies found that alcohol altered sleep architecture, including delayed REM onset and reduced REM sleep. REM disruption was seen even at relatively low doses and worsened as alcohol intake increased. (PubMed⁠)5. Red wine is not cardiovascular medicine.Some observational studies historically suggested cardiovascular benefits from light-to-moderate alcohol use, but newer analyses have challenged a clear protective effect. The American Heart Association advises people who do not currently drink not to start drinking for health benefits. (professional.heart.org⁠)6. Alcohol and breast-cancer risk deserve an honest conversation.Alcohol is a known human carcinogen. NIAAA currently notes that even approximately one drink per day is associated with a 5% to 15% higher breast-cancer risk compared with women who do not drink.That statistic describes population-level risk. It does not mean one glass of wine “causes” breast cancer in an individual woman. It is information women deserve when deciding what level of alcohol exposure feels acceptable to them. (NIAAA⁠)7. Know what “one drink” actually means.In the United States, one standard drink contains approximately 14 grams of pure alcohol:12 oz regular beer at about 5% ABV5 oz wine at about 12% ABV1.5 oz distilled spirits at about 40% ABVA cocktail, restaurant pour or large home wine glass may contain more than one standard drink. (NIAAA⁠)8. You do not have to simply tolerate ...
    続きを読む 一部表示
    1 時間 4 分
  • Episode 39: “The Pellet Factory Problem: Why One-Size-Fits-All Hormone Therapy Should Worry You”

    Episode 39: “The Pellet Factory Problem: Why One-Size-Fits-All Hormone Therapy Should Worry You”
    2026/08/12
    Hormone pellets are everywhere—from social media ads to hormone clinics promising more energy, better libido, improved strength, and an easier way to manage menopause symptoms.But are hormone pellets actually right for you?In this episode of The Modern Midlife Collective, Dr. Jillian Woodruff and Dr. Ade Akindipe take an evidence-based look at bioidentical hormone pellets—what they are, how they work, where they may be helpful, and the important trade-offs you should understand before having one inserted.They also tackle one of the biggest misconceptions in hormone therapy: the word “bioidentical.” Bioidentical doesn't automatically mean safer, more natural, or customized. It describes the molecular structure of the hormone—and many FDA-approved hormone therapy options are bioidentical too.And there’s another important consideration with pellets: once a pellet is inserted, the dose cannot simply be turned down or adjusted the way it can with a patch, gel, or pill. You're committing to that delivery method for the life of the pellet.That doesn't mean pellets are inherently bad. For the right patient, with thoughtful dosing and appropriate monitoring, they may be a useful option.The key word is individualized.✨ Hormone therapy should fit the patient—not the clinic's business model.✨ “Bioidentical” doesn't automatically mean “safer.”✨ And no single hormone delivery method is right for every woman.In this episode, we discuss:What bioidentical hormone pellets actually are and how they workWhat “bioidentical” really means—and what it doesn'tThe difference between compounded pellets and FDA-approved hormone therapyWhy pellets can sometimes produce supraphysiologic, or above-normal, hormone levelsThe biggest limitation of pellets: why dosing can't easily be adjusted once they're insertedWhy appropriate monitoring matters throughout hormone therapyThe importance of progesterone when estrogen is used in women with a uterusThe potential role of testosterone in libido, energy, and muscle strengthWhy the goal of testosterone therapy should be symptom improvement—not chasing the highest hormone levelWho may be a good candidate for hormone pelletsQuestions to ask before choosing a hormone delivery methodWhy a clinic that offers the exact same treatment to every patient should make you ask more questionsThe truth about hormone pelletsHormone pellets aren't automatically “good” or “bad.”They're one delivery method among several.The right hormone therapy depends on your symptoms, medical history, individual risk factors, treatment goals, response to therapy, and appropriate clinical monitoring.Pellets also come with a unique trade-off: unlike some other hormone delivery methods, the dose cannot be easily changed after insertion.That's why an informed conversation before treatment matters.If every patient who walks through a clinic's door is offered the same hormone treatment—regardless of her history, symptoms, or individual needs—that isn't truly personalized hormone care.You deserve to understand your options, the benefits, the limitations, and the risks before making your decision.Key TakeawayThere is no one-size-fits-all approach to hormone therapy.Pellets may be appropriate for some women, while patches, gels, creams, oral medications, or other approaches may make more sense for others.The goal isn't to choose the trendiest delivery method.It's to choose the right treatment, at the right dose, for the right patient—with appropriate follow-up and monitoring.🎧 Considering hormone pellets—or already using them? Listen before your next appointment and bring your questions with you.If this episode helped clarify your options, share it with another woman navigating hormone therapy in midlife.Download Your Free Hormone Therapy Methods Guide📩 Have a question or topic you'd like us to discuss?Visit modernmidlifecollective.com or email us at connect@modernmidlifecollective.com.Resources MentionedThe Menopause Society — Hormone therapy information and clinical guidanceAmerican College of Obstetricians and Gynecologists (ACOG) — Guidance on compounded bioidentical menopausal hormone therapyWomen's Health Initiative — Research and long-term follow-up on menopausal hormone therapyReviews published in American Journal of Obstetrics & Gynecology and Obstetrics & Gynecology addressing compounded hormone therapy and endometrial safety#HormonePellets#BioidenticalHormones#HormoneTherapy#HRT#Perimenopause#MenopauseSupport#HormoneHealth#WomenOver40#MidlifeWellness#ModernMidlifeCollective
    続きを読む 一部表示
    59 分
  • Episode 38: Brain Fog, ADHD, or Both? How Perimenopause Changes Your Brain

    Episode 38: Brain Fog, ADHD, or Both? How Perimenopause Changes Your Brain
    2026/07/29

    Is that brain fog… or something more? Dr. Jillian and Dr. Ade break down how to actually tell the difference between perimenopausal brain fog, adult ADHD, and the surprisingly common overlap between the two — plus why so many women are only being diagnosed with ADHD for the first time in their 40s and 50s. They walk through the clues that separate the two, the estrogen-dopamine connection driving it all, how it shows up in relationships and parenting, and exactly what to say at your next appointment.

    SHOW NOTES

    If the brain you’ve relied on for decades suddenly feels unreliable, you’re not lazy, careless, or incapable — and you may be one of three things: experiencing genuine perimenopausal brain fog, uncovering ADHD that’s been masked for decades, or dealing with both at once. In this episode, Dr. Jillian and Dr. Ade walk through the exact framework they use in clinic to help you tell the difference.

    In this episode:

    • What ADHD actually is: current presentations (predominantly inattentive, predominantly hyperactive-impulsive, combined), and why “ADD” is now called ADHD, predominantly inattentive presentation
    • The three-bucket framework: perimenopausal cognitive change, undiagnosed ADHD surfacing, or both together
    • Four clues that help separate them — timing and history, how broad the symptoms are, where they show up, and how much effort it’s taken to compensate
    • The estrogen-dopamine connection: why hormonal transition changes the environment attention and executive function operate in
    • Why so many women are only recognizing ADHD in midlife, and the historical gap in how girls were diagnosed
    • How this shows up at the kitchen table — in marriages, parenting, and intimacy
    • What actually helps, and exactly what to say at your next appointment

    By the numbers:

    • Nearly 60% of perimenopausal women report real memory complaints, per the Study of Women’s Health Across the Nation (SWAN)
    • A 2025 population-based study of over 5,300 women (the Icelandic SAGA cohort) found 54.2% of women with a self-reported ADHD diagnosis experienced debilitating perimenopausal symptoms, compared to about a third of women without ADHD

    Resources & sources referenced:

    • Study of Women’s Health Across the Nation (SWAN) — longitudinal research on cognition and symptoms across the menopause transition
    • Weber, M. T., Maki, P. M., & McDermott, M. P. (2014). Cognition and mood in perimenopause: A systematic review and meta-analysis. The Journal of Steroid Biochemistry and Molecular Biology.
    • Jakobsdóttir Smári, U., et al. (2025). Perimenopausal symptoms in women with and without ADHD: A population-based cohort study. European Psychiatry.
    • Kooij, J. J. S., et al. (2025). Research advances and future directions in female ADHD: The lifelong interplay of hormonal fluctuations with mood, cognition, and disease. Frontiers in Global Women’s Health.
    • Osianlis, E., et al. (2025). ADHD and sex hormones in females: A systematic review. Journal of Attention Disorders.
    • DSM-5-TR. American Psychiatric Association. (2022). ADHD diagnostic criteria and presentation terminology.

    Have a question or want to learn more? Reach out at connect@modernmidlifecollective.com.


    DR. JILLIAN

    “If the brain you have relied on for forty years suddenly feels unreliable, you are not becoming lazy, careless, or incapable.”

    “The coping did not fail. The floor moved. Now the support system has to move with it.”

    DR. ADE

    “Success does not rule out ADHD. The more useful question is: what did that success cost?”

    “You do not need to be falling apart dramatically before asking for help. Quietly working twice as hard to maintain the same life is enough.”
    続きを読む 一部表示
    38 分
  • Episode 37: "I Think I'm in Perimenopause — When Do I Start Progesterone?"

    Episode 37: "I Think I'm in Perimenopause — When Do I Start Progesterone?"
    2026/07/15

    If you're in your late 30s or 40s, waking up at 3 a.m., and wondering why your anxiety is through the roof and your cycles are changing — this episode is for you. Dr. Jill and Dr. Ade break down everything you need to know about perimenopause and progesterone: what progesterone actually does (hint: it's way more than a "pregnancy hormone"), why bioidentical progesterone is different from synthetic progestins, and the clinical decision framework for when to start. Real science. No fear. Just answers.

    In Episode 37, Dr. Jill Woodruff (gynecologist and certified menopause practitioner) and Dr. Ade Akindipe (DNP, functional medicine specialist) tackle the most common question they hear from women in their 40s: "I think I'm in perimenopause — when do I start progesterone?"

    This episode covers:

    • What perimenopause actually is and when it starts (hint: much earlier than you think)

    • Why progesterone is often the first hormone to decline — and what that means for your sleep, mood, and cycles

    • The critical difference between bioidentical progesterone and synthetic progestins

    • Why the Women's Health Initiative doesn't apply to modern bioidentical hormone therapy

    • Three clinical scenarios where progesterone is indicated in perimenopause

    • How to talk to your provider and advocate for the care you deserve

    GUEST DETAILS:

    This is a co-host episode featuring Dr. Jillian Woodruff, MD, FACOG, NCMP (CMO, Modern Gynecology & Skin) and Dr. Ade Akindipe, DNP, MBA, APRN, FNP-C (Founder, Rejuvenate Health and Wellness).
    続きを読む 一部表示
    40 分
  • Episode 36: The Menopause Toolkit Every Woman Needs Before Her Next Doctor's Visit

    Episode 36: The Menopause Toolkit Every Woman Needs Before Her Next Doctor's Visit
    2026/07/01

    What happens when a patient decides she deserves better?

    After experiencing years of frustrating symptoms and feeling dismissed by the healthcare system, Angela Jackson, LMSW, turned her own journey into a mission to help other women.

    In this episode, Angela shares the story behind her graduate capstone project—a comprehensive Perimenopause & Menopause Toolkit designed to educate women, improve communication with healthcare providers, and empower patients to become active participants in their own care. The toolkit is available as a free download in the resources below.

    Together, Dr. Jillian Woodruff and Dr. Ade Akindipe explore why so many women remain undiagnosed during perimenopause, the importance of recognizing early symptoms, racial disparities in menopause care, and how patients and providers can work together to create better outcomes.

    This conversation is a reminder that menopause isn't simply something to survive—it's a life transition women can navigate with knowledge, partnership, and confidence.

    What You'll Learn

    • Why women are frequently dismissed during perimenopause
    • The hidden symptoms many women overlook
    • How to prepare for your next healthcare appointment
    • Why patient self-advocacy changes healthcare outcomes
    • The importance of provider-patient collaboration
    • What health equity means in menopause care
    • Why thriving—not suffering—should be the goal

    Featured Guest

    Angela Jackson, LMSW

    Angela Jackson recently earned her Master of Social Work and developed a Perimenopause & Menopause Toolkit as her graduate capstone project. Grounded in trauma-informed care, patient empowerment, and health equity, the toolkit helps women understand symptoms, prepare for medical appointments, and confidently advocate for their healthcare needs.

    Key Takeaways

    • You know your body better than anyone else.
    • Your symptoms deserve to be taken seriously.
    • Perimenopause often begins years before menopause.
    • Being informed allows you to become an active participant in your healthcare.
    • The best healthcare happens through partnership—not one-sided conversations.
    • Every woman deserves to thrive during midlife.

    Suggested Chapter Markers

    00:00 – Why women often feel dismissed

    02:45 – Meet Angela Jackson

    06:00 – The inspiration behind the Menopause Toolkit

    12:00 – Learning to advocate for yourself

    16:30 – Building a toolkit for patients and providers

    20:00 – Racial disparities in menopause care

    24:00 – Why earlier conversations matter

    30:00 – Practical advice for your next doctor's appointment

    35:00 – Final reflections

    Resources Mentioned

    • Perimenopause symptom awareness
    • Patient self-advocacy
    • Shared decision-making between patients and providers
    • Trauma-informed healthcare
    • SWAN (Study of Women's Health Across the Nation)


    Free Download

    📥 Download Angela Jackson's Perimenopause & Menopause Toolkit

    Angela created this comprehensive educational toolkit to help women better understand perimenopause and menopause, recognize common symptoms, prepare for healthcare appointments, and confidently advocate for their care.

    Whether you're just beginning to notice changes or you're already navigating menopause, this free resource is designed to help you feel informed, empowered, and prepared.

    👉 Download the toolkit here
    続きを読む 一部表示
    53 分
  • Episode 35: Am I Crazy, or Is This Perimenopause?

    Episode 35: Am I Crazy, or Is This Perimenopause?
    2026/06/17
    Am I Crazy, or Is This Perimenopause?The Modern Midlife Collective PodcastEpisode OverviewHave you been told your labs are normal -- but you still don't feel like yourself? Are you waking up at 3 a.m., snapping at people you love, forgetting words mid-sentence, and wondering what is happening to your body? Before you assume the worst, there's something you need to hear: you are not crazy. You may be in perimenopause.In this foundational episode, Dr. Jillian Woodruff, MD, FACOG, MSCP, and Dr. Ade Akindipe, DNP, break down everything women need to know about the menopausal transition -- what it actually is, why it begins earlier than most women expect, and why the symptom list goes so far beyond hot flashes. They explain why perimenopause is a clinical diagnosis rather than a laboratory one, what the research actually shows about hormones and brain health, and what to do if you have already been dismissed by a provider who told you your numbers look fine.This episode also addresses why so many perimenopausal symptoms are misattributed to anxiety, stress, or aging -- and what the full, evidence-based picture actually looks like. If you have been searching for someone to finally connect the dots, this is that conversation.Key Takeaways• Perimenopause can begin in the late 30s and lasts an average of four to ten years -- and women can be fully symptomatic while still having regular menstrual cycles.• Hormone levels fluctuate dramatically during this transition. A single blood draw is a snapshot, not the full film. Perimenopause is a clinical diagnosis based on symptoms, history, and patterns over time.• Estrogen receptors are found in the brain, bones, heart, blood vessels, bladder, skin, and muscles. When estrogen fluctuates, women feel it throughout their entire body -- which explains why the symptom list seems so disconnected.• The SWAN Study (Study of Women's Health Across the Nation), one of the largest long-term studies of the menopausal transition, confirmed that sleep disruption, mood changes, cognitive complaints, and hot flashes commonly emerge during perimenopause -- often well before the final menstrual period.• Cognitive changes -- word-finding difficulties, brain fog, and memory lapses -- are common during perimenopause and are typically temporary and hormone-related. They are not early dementia.• Tracking your symptoms over four to six weeks -- including sleep, mood, energy, cycle changes, hot flashes, brain fog, and joint pain -- gives your clinician critical information that a single lab result cannot provide.• Evidence-based treatment options exist. There is no clinical or moral virtue in suffering through this transition without support.Topics DiscussedWhat perimenopause is and how it differs from menopause, why perimenopause can begin in the late 30s, the hormone fluctuation pattern during perimenopause and why it is not a steady decline, the full symptom spectrum of perimenopause including neurological, cardiovascular, musculoskeletal, urogenital, and metabolic symptoms, the SWAN Study and what it tells us about the menopausal transition, estrogen and the brain including research from Harvard Medical School and Brigham and Women's Hospital, the ACOG position on perimenopause symptom onset, why perimenopause is a clinical diagnosis and not a laboratory diagnosis, the limitations of hormone testing and what labs actually tell us, conditions that mimic perimenopause including thyroid disease, iron deficiency, and insulin resistance, why perimenopausal anxiety is frequently misattributed to stress, the cognitive changes of perimenopause and why they are temporary, building your midlife foundation using the CARESS framework, how to find a Menopause Society certified practitioner, listener questions addressing the most common perimenopause misconceptionsYour Five-Step Perimenopause Action Plan1. Track your symptoms for four to six weeks. Include sleep, mood, energy, hot flashes, brain fog, cycle changes, joint pain, and libido. Patterns are data your clinician needs.2. Know your family history. Ask when your mother or sisters reached menopause and whether they experienced osteoporosis, heart disease, or cognitive changes.3. Build your midlife foundation. Prioritize protein at every meal, resistance training two to three times per week, daily movement, stress management, and sleep. The CARESS framework is a place to start.4. Find a clinician with menopause-specific training. The Menopause Society maintains a certified practitioner directory at menopause.org.5. Give yourself grace. You are not weak. You are not lazy. You are moving through a transition -- and you deserve support during it.Resources MentionedThe Menopause Society certified practitioner directory: menopause.orgACOG (American College of Obstetricians and Gynecologists): acog.orgSWAN Study (Study of Women's Health Across the Nation): swanstudy.orgModern Gynecology and Skin: moderngynalaska.comRejuvenate Health and ...
    続きを読む 一部表示
    43 分